These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3913454)

  • 1. [Insulin resistance in chronic liver disease: the possible role of anti-insulin factors].
    Buzzelli G; Cotrozzi G; Relli P; Orioli S; Matassi L; Simondi P; Gentilini P
    Boll Soc Ital Biol Sper; 1985 Oct; 61(10):1431-8. PubMed ID: 3913454
    [No Abstract]   [Full Text] [Related]  

  • 2. [Active chronic hepatitis and insulin resistance: possible role of glucagon, GH and free fatty acids].
    Bonora E; Coscelli C; Orioli S; Cambi R; Buzzelli G; Gentilini P; Butturini U
    G Clin Med; 1981 Dec; 62(12):831-45. PubMed ID: 7042433
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucose intolerance and insulin resistance in patients with liver disease. II. A study of etiologic factors and evaluation of insulin actions.
    Collins JR; Lacy WW; Stiel JN; Crofford OB
    Arch Intern Med; 1970 Oct; 126(4):608-14. PubMed ID: 5506964
    [No Abstract]   [Full Text] [Related]  

  • 4. [Insulin resistance in liver diseases].
    Petrides AS; Strohmeyer G
    Z Gastroenterol; 1986 Aug; 24(8):403-15. PubMed ID: 3532594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Variations in glycoregulatory factors during hemodialysis].
    Ducros J; Mahfoud A; Vague P; Olmer M
    J Urol Nephrol (Paris); 1978 Sep; 84(9):655-7. PubMed ID: 748586
    [No Abstract]   [Full Text] [Related]  

  • 6. Possible roles of insulin, glucagon, growth hormone and free fatty acids in the pathogenesis of insulin resistance of subjects with chronic liver diseases.
    Bonora E; Orioli S; Coscelli C; Buzzelli G; Gentilini P; Butturini U
    Acta Diabetol Lat; 1984; 21(3):241-50. PubMed ID: 6393673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperinsulinaemia and impaired glucose tolerance in chronic inflammatory liver disease (author's disease)].
    Oehler G; Bleyl H; Knecht M; Matthes K
    Z Gastroenterol; 1981 Jan; 19(1):26-32. PubMed ID: 7222867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone, insulin-like growth factor-1 and insulin resistance in cirrhosis.
    Shmueli E; Stewart M; Alberti KG; Record CO
    Hepatology; 1994 Feb; 19(2):322-8. PubMed ID: 7904978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
    Giugliano D; Luyckx AS; Lefebvre PJ
    Diabete Metab; 1980 Mar; 6(1):39-46. PubMed ID: 6989660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observations on glucose tolerance, serum insulin and free fatty acid in chronic liver disease.
    Parida RK; Santhalia RR; Mishra PK; Pradhan N; Samal KC; Sahoo CS
    J Assoc Physicians India; 1981 Feb; 29(2):119-27. PubMed ID: 7021524
    [No Abstract]   [Full Text] [Related]  

  • 11. [Free fatty acids, glucose, insulin and growth hormone in the blood of patients with thyroid diseases].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1972 Sep; 111(36):829-32. PubMed ID: 5072749
    [No Abstract]   [Full Text] [Related]  

  • 12. Temporal changes in insulin sensitivity following the development of acute liver failure secondary to acetaminophen.
    Clark SJ; Shojaee-Moradie F; Croos P; Seed PT; Umpleby AM; Wendon JA; Miell J
    Hepatology; 2001 Jul; 34(1):109-15. PubMed ID: 11431740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of the antidiabetic action of sulfanylurea derivatives].
    Iaroshevskiĭ IuA; Volkova EA
    Klin Med (Mosk); 1982 Oct; 60(10):94-7. PubMed ID: 6757562
    [No Abstract]   [Full Text] [Related]  

  • 14. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease.
    Donaghy A; Ross R; Gimson A; Hughes SC; Holly J; Williams R
    Hepatology; 1995 Mar; 21(3):680-8. PubMed ID: 7533122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of glucose, insulin, and lipid metabolism in amyotrophic lateral sclerosis and other neuromuscular disorders.
    Mueller PS; Quick DT
    J Lab Clin Med; 1970 Aug; 76(2):190-201. PubMed ID: 5434000
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipoprotein and carbohydrate disorders in nephrotic syndrome and uremia.
    Kleinknecht D; Laudat MH; Strauch G; Jungers P; Laudat P
    Rev Eur Etud Clin Biol; 1972 Jan; 17(1):27-37. PubMed ID: 5041347
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum cholinesterase activity correlates with serum insulin, C-peptide and free fatty acids levels in patients with type 2 diabetes.
    Cucuianu M; Nistor T; Hâncu N; Orbai P; Muscurel C; Stoian I
    Rom J Intern Med; 2002; 40(1-4):43-51. PubMed ID: 15526539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum glucose, insulin, and growth hormone in chronic hepatic cirrhosis.
    Samaan NA; Stone DB; Eckhardt RD
    Arch Intern Med; 1969 Aug; 124(2):149-52. PubMed ID: 5797073
    [No Abstract]   [Full Text] [Related]  

  • 19. [Methods for the characterization of glucose turnover and the peripheral insulin resistance in human prediabetic conditions].
    Ratzmann KP; Witt S
    Z Gesamte Inn Med; 1979 Oct; 34(19):561-5. PubMed ID: 396726
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of trimepranol on somatotropin, insulin, glucose and on serum free fatty acids in thyrotoxicosis].
    Felt V; Nedvídková J
    Vnitr Lek; 1973 Apr; 19(4):374-8. PubMed ID: 4144647
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.